Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Explore the molecular pharmacology and antitumor activity of PHT-427, a novel dual-targeting inhibitor of Akt and PDPK1 with promising cancer therapeutic potential.